| 000 | 01716 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518013005.0 | ||
| 264 | 0 | _c20200211 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1559-0259 | ||
| 024 | 7 |
_a10.1007/s12012-018-9495-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWan, Guo-Xing | |
| 245 | 0 | 0 |
_aMiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte. _h[electronic resource] |
| 260 |
_bCardiovascular toxicology _c06 2019 |
||
| 300 |
_a264-275 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtoxicity |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBone Morphogenetic Protein Receptors, Type I _xgenetics |
| 650 | 0 | 4 | _aCardiotoxicity |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDoxorubicin _xtoxicity |
| 650 | 0 | 4 |
_aGATA4 Transcription Factor _xgenetics |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 |
_aMembrane Potential, Mitochondrial _xdrug effects |
| 650 | 0 | 4 |
_aMicroRNAs _xgenetics |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
| 700 | 1 | _aCheng, Lan | |
| 700 | 1 | _aQin, Hai-Lun | |
| 700 | 1 | _aZhang, Yun-Zhang | |
| 700 | 1 | _aWang, Ling-Yu | |
| 700 | 1 | _aZhang, Yong-Gang | |
| 773 | 0 |
_tCardiovascular toxicology _gvol. 19 _gno. 3 _gp. 264-275 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12012-018-9495-6 _zAvailable from publisher's website |
| 999 |
_c29148860 _d29148860 |
||